Article
Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance
3 Jun 2024
Abstract excerpt
Prostate cancer (PCa) is commonly occurred with high incidence in men worldwide, and many patients will be eventually suffered from the dilemma of castration-resistance with the time of disease progression. Castration-resistant PCa (CRPC) is an advanced subtype of PCa with heterogeneous carcinogenesis, resulting in poor prognosis and difficulties in therapy. Currently, disorders in androgen receptor (AR)-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
